Go to main content

  1. Home
  2. European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2020 workplan

UK - Department of Health and Social Care (DHSC)

European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2020 workplan

Disclaimer: The data for this page has been produced from IATI data published by UK - Department of Health and Social Care (DHSC). Please contact them (Show Email Address) if you have any questions about their data.

Programme Data Last Updated: 11/11/2022

IATI Identifier: GB-GOV-10-EDCTP2_2020WP

Description

The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2020 Workplan focussed on: ‘Mobilisation of funding for COVID-19 research in sub-Saharan Africa’; ‘Addressing gender and diversity gaps in clinical research capacity at the EDCTP Regional Networks of Excellence; and ""Capacity development for disease outbreak and epidemic response in sub-Saharan Africa, in collaboration with Africa Centres for Disease Control and Prevention (Africa CDC)"". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).

Objectives

The activities of the EDCTP2 programme will contribute towards achieving the following five specific objectives: Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.

Status - Implementation More information about Programme status
Programme Spend More information about Programme funding
Participating Organisation(s) More information about implementing organisation(s)

This site uses cookies

We use Google Analytics to measure how you use the website so we can improve it based on user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the internal pages you visit, how long you spend on each page and what you click on while you're visiting the site. Read more